Connect with us

Business

Third member of US FDA advisory panel resigns over Alzheimer’s drug approval – Fox Business

Published

on

Article feature image
ADVERTISEMENT

A third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agency’s decision to approve Biogen Inc’s Alzheimer’s disease treatment despite the committee’s recommendation against doing so.
Aaron…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
California Flex Alert extended for Friday amid high heat – KCRA Sacramento
Article feature image
Cruise giant Carnival says customers affected by breach – ABC News
Article feature image
New Nielsen Measurement Shows Streaming Usage Outrunning Broadcast TV In May – Deadline